The -amyloid precursor protein (APP) 1 is a ubiquitously expressed cell membrane protein that is sequentially cleaved by -secretase and ␥-secretase to release extracellular peptides (including the -amyloid peptides, which are deposited in the brain in Alzheimer's disease) and the APP intracellular domain (AID) (reviewed in Ref. 1).The biological function of APP and the factor(s) that trigger the APP proteolytic cascade remain unclear. APP and its two closely related homologues, APP-like protein (APLP) -1 and -2, appear to share redundant but essential function(s), because mice with single knockouts of these genes only show mild phenotypic abnormalities, whereas double and triple knockouts are lethal in the prenatal period (2). ␥-Secretase cleavage of APP requires nicastrin and presenilins (reviewed in Ref.3). Presenilins and APP are the only identified proteins known to be mutated in cases of familial Alzheimer's disease. Presenilins are also required for the ␥-secretase proteolysis of the cellsurface receptor Notch (4), which releases the Notch intracellular domain (NICD) that translocates to the nucleus where it acts as a transcriptional regulator (5). Evidence is accumulating that APP is a receptor-like protein (6) whose function is mediated by AID, analogous to Notch/NICD (7-10). Peptides consistent with AID have been detected in brain homogenates of Alzheimer's and elderly control subjects (7-8) and in metabolically labeled cells (9). Overexpression of AID induces apoptosis or may augment apoptosis triggered by other factors (8), offering a potential mechanistic explanation for data functionally linking APP and presenilins to enhanced neuronal apoptosis (11-15). APP interacts via its cytoplasmic tail with a number of cytoplasmic proteins, including Fe65, X11, and murine DAB 1 (16 -18), all of which share characteristics of adapter proteins that could potentially link APP to intracellular signaling pathways. APP may anchor Fe65 in the cytosol, whereas the release of AID from APP by ␥-cleavage may allow the AID-Fe65 complex to translocate to the nucleus where it acts as a transcription factor (10, 19).To identify cellular pathways to which the AID peptide may signal, we used the yeast 2-hybrid system to identify proteins with which AID may interact. As expected, our yeast 2-hybrid screen identified known APP-interacting proteins, including Fe65 and X11. We (20) and others (21) recently identified human c-JUN N-terminal kinase (JNK) interacting protein (JIP)-1 as a novel APP-binding protein. X11, Fe65, mDAb-1, and JIP-1 share as a common feature the presence of phosphotyrosine binding (PTB) domains. PTB domains are protein interaction domains that bind tyrosine residues located within the cytoplasmic tails of activated cellular receptors (22-23). To investigate further the interaction between APP and the proteins identified in the yeast 2-hybrid screen, we performed glutathione S-transferase (GST) binding and co-immunoprecipitation experiments. As a negative control for these assays, we used the PTB domai...